Leap Investments’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-25,100
Closed -$390K 470
2019
Q3
$390K Buy
+25,100
New +$390K 0.19% 190